A tri-phytochemical formula improves skin barrier function and regulates immune response in atopic dermatitis-like mice

Keyphrases

• Immune Response 100%
• Phytochemicals 100%
• Atopic Dermatitis 100%
• Skin Barrier Function 100%
• Dermatitis 50%
• Mouse Model 37%
• Mouse Ear 37%
• Anti-atopic Dermatitis 37%
• Spleen 25%
• Protein Level 25%
• Mitogen-activated Protein Kinase 25%
• Topical Application 25%
• Ginsenoside Rg1 25%
• Icariin 25%
• Tetrandrine 25%
• Tumor-draining Lymph Nodes 25%
• Calcipotriol 25%
• Mechanism of Action 12%
• Safe Drugs 12%
• Inflammatory Cytokines 12%
• Interleukin-1β 12%
• Mast Cells 12%
• CD4+ T Cells 12%
• Beneficial Effects 12%
• Kinase Activation 12%
• Phospho-p38 12%
• Suppression Effect 12%
• Disease Severity 12%
• Phospho-ERK 12%
• Interleukin-4 (IL-4) 12%
• Effective Compounds 12%
• Allergic Rhinitis 12%
• JNK1 12%
• Zonula occludens-1 (ZO-1) 12%
• Claudin-1 12%
• Intestinal Barrier Function 12%
• Tight Junction Proteins 12%
• T Cell Activation 12%
• Epidermal Thickness 12%
• Allergic Reaction 12%
• Eosinophil Cells 12%
• IgE Levels 12%
• Skin Barrier Dysfunction 12%
• MC903 12%
• Non-IgE 12%
• IgE-mediated 12%
• IgE-mediated Allergy 12%
• Response Enhancement 12%
• Dermis Thickness 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Phytochemical 100%
• Atopic Dermatitis 100%
• Mouse Model 45%
• Immunoglobulin E 45%
• Dermatitis 36%
• Calcipotriol 27%
• Mitogen Activated Protein Kinase 18%
• Ginsenoside Rg 1 18%
• Icariin 18%
• Allergic Reaction 18%
• Tetrandrine 18%
• Cytokine 9%
• Interleukin 1 9%
• Dexamethasone 9%
• Interleukin 4 9%
• Claudin 1 9%
• Allergic Rhinitis 9%
• Disease Severity 9%
• Tight Junction Protein 9%